Methods: Cases of newly diagnosed HIV infection are notifiable in each state/territory in Australia and then forwarded to the National HIV Registry for national collation and analysis. Information is routinely collected on date of HIV diagnosis, CD4+ cell count and newly acquired HIV status. Cases previously diagnosed overseas were excluded from analyses.
Results: Mean CD4+ cell count was 453 cells/μl in 2001–2006 and 450 in 2007–2012. Among 3,466 (30%) cases of newly acquired infection, 60% and 56% diagnosed in 2001-2006 and 2007-2012, respectively, had a CD4+ cell count of 500 or higher, and less than 5% had a CD4+ cell count of less than 200 in 2001-2012. Among cases without evidence of newly acquired infection, mean CD4+ cell count was 396 in 2001-2006 and 398 in 2007-2012. The proportion of non-newly acquired cases with a CD4+ cell count of less than 200 declined from 32% in 2001 to 24% in 2007-2008 and increased to 27% in 2012. The proportion of non-newly acquired cases among men who have sex with men whose CD4+ cell count was less than 200 remained stable at around 20% in 2001 – 2012. Among cases attributed to injecting drug use or heterosexual contact, 24% and 30%, respectively, were diagnosed with a CD4+ cell count of less than 200.
Conclusion: The distribution of CD4+ cell count at HIV diagnosis has remained relatively stable over the last 12 years. HIV diagnosis at advanced HIV infection continues to occur in Australia at moderate levels.
The case is of a 30 year-old HIV positive Zimbabwean woman (UK resident) who arrived in Australia in January 2011 on a one-year working visa. She was diagnosed with HIV in 2003 in the UK and commenced on Atripla® in 2005. She was first seen in Adelaide in May 2011, requesting a script for Atripla.®.
Background: Liquid based anal Papanicolaou smears, followed by High Resolution Anoscopy (HRA) guided biopsies are increasingly being advocated to identify areas of High Grade Anal Intraepithelial Neoplasia (HGAIN). We hypothesized that the ability to identify HGAIN would increase with experience of the anoscopist, and that comparison with contemporary Papanicolaou smears might yield insights into technical abilities.
Indigenous Australians experience a greater burden of sexually transmitted infections, however are less likely than the general population to access sexual health services. We examined the effectiveness of an Indigenous cultural appropriateness audit in assessing a sexual health clinic with low rates of Indigenous clients.
Despite the high proportion of young people annually accessing general practices, including Aboriginal Medical Services (AMS), testing for Chlamydia trachomatis remains relatively low in urban areas. A project officer was employed within the Institute of Urban Indigenous Health (IUIH) to serve a mentoring and facilitation role for the SE Queensland network of AMS and their sexual health workers, with a view to improving testing, management and follow-up of chlamydia and other STIs by community controlled medical services.
Monocytes are a heterogeneous cell population having specialised functions and differing phenotype. They are a link between innate immune system and adaptive immune system therefore, to identify if immune activation exists in HIV-1 individuals with controlled virema and recovered CD4 T cell counts, we assessed cell surface monocyte activation markers (MAM) within the monocyte subsets.
Involving consumers in healthcare decisions is important for high quality care. We previously tested a brief, consumer-led intervention consisting of three questions in a trial employing trained, standardized patients. The intervention enhanced discussion of evidence and increased patient involvement. We now report a research translation study which tested implementation with real patients at a reproductive and sexual health clinic.
This presentation, "Responding to the needs of consumers with complex trauma histories a consumer perspective" focuses on the needs of adult survivors of child abuse, highlighting the frequent